Few U.S. adults in their 50s receive shingles vaccine

09/11/2013 | Healio · Bloomberg

Although the proportion of 50- to 59-year-olds receiving the herpes zoster vaccine jumped from 2.9% in 2008 to 4.3% in 2011, the rate remained relatively low, according to a study presented at the Interscience Conference on Antimicrobial Agents and Chemotherapy. Among adults aged 60 and older, the vaccination rate substantially increased from 6.7% in 2008 to 15.8% in 2011. "Socioeconomic factors such as income, education, race, and type of insurance may influence likelihood to be vaccinated," study author Melissa D. Johnson said.

View Full Article in:

Healio · Bloomberg

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Director of Program Development
AdvaMed
Washington DC, DC
Director of System QA
LifeWatch Services, Inc.
Rosemont, IL
Director of Business Development and Membership
AdvaMed
Washington DC, DC
Director, Corporate Counsel
Regeneron
Tarrytown, NY